HUNgarian COronaVirus Disease-19 Epidemiological Research

Coronavirus Infection Clinical Trial

Official title:

Hungarian CoronaVirus Disease-19 Epidemiological Research

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04370067
• Other study ID #: H-UNCOVER
• Status: Recruiting
• Start date: May 1, 2020
• Est. completion date: August 1, 2021

Study information

• Verified date: June 2020
• Source: Semmelweis University Heart and Vascular Center
• Contact: Béla Merkely, PhD,DSc
• Phone: +36 20 825 8000
• Email: rektor[@]semmelweis-univ.hu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Hungarian CoronaVirus disease-19 Epidemiological Research

Description:

The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 11200
• Est. completion date: August 1, 2021
• Est. primary completion date: May 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years and older

Eligibility

Inclusion Criteria:

• Hungarian male or female patients aged 14 and over who live in private households

• Inactivated social security number does not infer the exclusion of the study

Exclusion Criteria:

• Patients under the age of 14

• Patients living in institutional households

Related Conditions & MeSH terms

• Coronavirus Infection
• Coronavirus Infections
• Severe Acute Respiratory Syndrome

Locations

Country	Name	City	State
Hungary	Semmelweis University - Heart and Vascular Center	Budapest
Hungary	University of Debrecen	Debrecen
Hungary	University of Pecs	Pecs
Hungary	University of Szeged	Szeged

Sponsors (5)

Lead Sponsor	Collaborator
Semmelweis University Heart and Vascular Center	Semmelweis University, Szeged University, University of Debrecen, University of Pecs

Country where clinical trial is conducted

Hungary, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	COVID-19 rate	The rate of the infected patients, asymptomatic carrier and healed patients	1 year